SOLACE - Strengthening the screening of Lung Cancer in Europe
In the EU in 2020, lung cancer was the second-most common cancer among males and the third-most common among females, with an estimated incidence of 97.2 per 100 000 males and 43.9 per 100 000 females. Among all cancers, it has been the leading cause of death for both sexes since 2017.
Screening using low-dose computed tomography (LDCT) can detect lung cancer early, reducing mortality by at least 20%.
SOLACE thus aims to:
- improve lung cancer screening across Europe by supporting the implementation and optimisation of LDCT screening programmes;
- providing a modular framework (toolbox) that tailors screening approaches to national or regional needs so as to address health inequalities, increase life expectancy, improve quality of life and ensure cost-effectiveness;
- bring together all key stakeholders to design, plan and implement sustainable lung cancer screening.
- Project duration
- 1 Apr 2023 - 31 Mar 2026
- Project locations
- AustriaBelgiumCzechiaCroatiaEstoniaFranceGermanyGreeceHungaryIrelandItalyNetherlandsPolandRomaniaSpain
- Overall budget
- €12 134 209
- EU contribution
- €9 707 36780% of the overall budget
- Project website
- Strengthening the screening of Lung Cancer in Europe
- EU4health - Projects
- Early detection
Factsheet - SOLACE
Results
Expected results:
In the long term, SOLACE will provide valuable knowledge on how best to implement cost-effective lung cancer screening programmes and ensure that high-risk groups have access to high-quality screening.
Specific outcomes include:
- creation of a Lung Cancer Screening Guideline with Quality Assurance Parameters
- needs assessments of Member States, taking into account differing epidemiology and at-risk groups;
- periodic information on benefit-harm balance and cost-effectiveness of screening;
- regular review of new approaches;
- pilot projects to assess the feasibility of the screenings based on the requirements of national or regional health authorities;
- at least three highly visible conferences on lung cancer screening.
Stakeholders
Coordinators
European Institute for Biomedical Imaging Research (EIBIR)
- Address
- Am Gestade 1, 1010 Vienna, Austria
- Website
- https://www.eibir.org/
Contact
Ms. Monika Hierath
- Name
- Ms. Monika Hierath
- Organisation
- EIBIR
- office
eibir [dot] org - Phone number
- +43-1-533-4064-20
